Blood Collection Monitor companies

  • Report ID: 3992
  • Published Date: Sep 24, 2025
  • Report Format: PDF, PPT

Key Blood Collection Monitor Market Players:

    The market is marked by significant global competition. There is an emerging focus on automation, patient safety, and decentralized diagnostics. Leading players in the market are established and use sophisticated systems and processes. Players in the APAC region are developing somewhat less expensive monitors by creating portable blood collection monitors for emerging markets. Companies, including developed and emerging market companies, are innovating, developing new regional penetration strategies, and exploring pricing and strategy to define a premium price.

    Such key players are:

    • Fresenius SE & Co. KGaA
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Haemonetics Corporation
    • Terumo BCT
    • Becton, Dickinson and Company (BD)
    • Greiner Bio-One International GmbH
    • Macopharma
    • Grifols, S.A.
    • Lmb Technologie GmbH
    • SARSTEDT AG & Co. KG
    • Barkey GmbH & Co. KG
    • Medicap GmbH
    • Kawasumi Laboratories, Inc.
    • Nipro Medical Corporation
    • Delfi Medical Innovations Inc.
    • SMS Technologies Pvt. Ltd.
    • Angiplast Pvt. Ltd.
    • Helmer Scientific
    • Bioelettronica
    • Braintree Scientific, Inc.
    • Stago
    • Tasso, Inc.
    • Fenwal, Inc. (part of Fresenius Kabi)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of the blood collection monitor market was over USD 2 billion.

The market size for the blood collection monitor market is projected to reach USD 3.6 billion by the end of 2035, expanding at a CAGR of 6.8% during the forecast period, i.e., between 2026-2035.

The major players in the market are Becton, Dickinson & Company, Terumo Corporation, Haemonetics Corporation, Fresenius Kabi AG, Greiner Bio-One International GmbH, and others.

In terms of product, the fully automatic BCM segment is anticipated to garner the largest market share of 61.4% by 2035 and display lucrative growth opportunities during 2026-2035.

The market in North America is projected to hold the largest market share of 32.5% by the end of 2035 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos